AI + EXCLUSIVE DATA
AI analyzes funding data you can't access anywhere else
Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.
10-25 personalized leads daily • 92% average intent score • Smart feed technology
Start with:
✓Flexible Plans • $39/mo or $29/mo annual
✓AI + real-time funding intelligence
✓Never see duplicates in your feed
INDUSTRY FIRST
Ansa Biotechnologies, Inc. announced it raised $5 Million in an initial filing from an offering of $5 Million
Oct 15, 2021•almost 4 years ago
Amount Raised
$5 Million
EmeryvilleBiotechnologyCompany Information
Company News
(7 articles)Thu, 22 Feb 2024 08:00:00 GMT
Ansa Biotechnologies Names Jason T. Gammack as CEO Amid Advances in DNA Synthesis Technology - SynBioBeta
Thu, 22 Feb 2024 08:00:00 GMT
Press Release Service: Ansa Biotechnologies Appoints Jason T. Gammack as CEO and Prepares for Launch of Rapid Enzymatic Synthesis Service for Complex DNA Sequences - CRISPR Medicine News
Tue, 12 Nov 2024 08:00:00 GMT
Ansa Biotechnologies Sets New Standard in Long, Complex DNA - Business Wire
Tue, 06 May 2025 07:00:00 GMT
Ansa Biotechnologies Breaks Traditional Synthetic DNA Length Barriers and Redefines Future of Life Science Research - SynBioBeta
Thu, 02 Jan 2025 08:00:00 GMT
Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech
Thu, 09 Mar 2023 08:00:00 GMT
Ansa Biotechnologies Announces Successful de novo Synthesis of World’s Longest Oligonucleotide at 1005 Bases - Business Wire
Wed, 22 Feb 2023 08:00:00 GMT
Ansa Bio Appoints Dr. Matthew McManus as Chair of the Board - Business Wire
FundzWatch™ Score
67
Medium Activity
Related People
Sign in to view contact details
Sign in to view contact details